Cargando…
SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
RATIONALE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558649/ https://www.ncbi.nlm.nih.gov/pubmed/36334378 http://dx.doi.org/10.1016/j.redox.2022.102508 |
_version_ | 1784807486777196544 |
---|---|
author | Archer, Stephen L. Dasgupta, Asish Chen, Kuang-Hueih Wu, Danchen Baid, Kaushal Mamatis, John E. Gonzalez, Victoria Read, Austin Bentley, Rachel ET. Martin, Ashley Y. Mewburn, Jeffrey D. Dunham-Snary, Kimberly J. Evans, Gerald A. Levy, Gary Jones, Oliver Al-Qazazi, Ruaa Ring, Brooke Alizadeh, Elahe Hindmarch, Charles CT. Rossi, Jenna Lima, Patricia DA. Falzarano, Darryl Banerjee, Arinjay Colpitts, Che C. |
author_facet | Archer, Stephen L. Dasgupta, Asish Chen, Kuang-Hueih Wu, Danchen Baid, Kaushal Mamatis, John E. Gonzalez, Victoria Read, Austin Bentley, Rachel ET. Martin, Ashley Y. Mewburn, Jeffrey D. Dunham-Snary, Kimberly J. Evans, Gerald A. Levy, Gary Jones, Oliver Al-Qazazi, Ruaa Ring, Brooke Alizadeh, Elahe Hindmarch, Charles CT. Rossi, Jenna Lima, Patricia DA. Falzarano, Darryl Banerjee, Arinjay Colpitts, Che C. |
author_sort | Archer, Stephen L. |
collection | PubMed |
description | RATIONALE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and bioenergetic impairment, and impairing hypoxic pulmonary vasoconstriction (HPV), respectively. OBJECTIVES: We examined the effects of: A) human betacoronaviruses, SARS-CoV-2 and HCoV-OC43, and individual SARS-CoV-2 proteins on apoptosis, mitochondrial fission, and bioenergetics in AEC; and B) SARS-CoV-2 proteins and mouse hepatitis virus (MHV-1) infection on HPV. METHODS: We used transcriptomic data to identify temporal changes in mitochondrial-relevant gene ontology (GO) pathways post-SARS-CoV-2 infection. We also transduced AECs with SARS-CoV-2 proteins (M, Nsp7 or Nsp9) and determined effects on mitochondrial permeability transition pore (mPTP) activity, relative membrane potential, apoptosis, mitochondrial fission, and oxygen consumption rates (OCR). In human PASMC, we assessed the effects of SARS-CoV-2 proteins on hypoxic increases in cytosolic calcium, an HPV proxy. In MHV-1 pneumonia, we assessed HPV via cardiac catheterization and apoptosis using the TUNEL assay. RESULTS: SARS-CoV-2 regulated mitochondrial apoptosis, mitochondrial membrane permeabilization and electron transport chain (ETC) GO pathways within 2 hours of infection. SARS-CoV-2 downregulated ETC Complex I and ATP synthase genes, and upregulated apoptosis-inducing genes. SARS-CoV-2 and HCoV-OC43 upregulated and activated dynamin-related protein 1 (Drp1) and increased mitochondrial fission. SARS-CoV-2 and transduced SARS-CoV-2 proteins increased apoptosis inducing factor (AIF) expression and activated caspase 7, resulting in apoptosis. Coronaviruses also reduced OCR, decreased ETC Complex I activity and lowered ATP levels in AEC. M protein transduction also increased mPTP opening. In human PASMC, M and Nsp9 proteins inhibited HPV. In MHV-1 pneumonia, infected AEC displayed apoptosis and HPV was suppressed. BAY K8644, a calcium channel agonist, increased HPV and improved SpO(2). CONCLUSIONS: Coronaviruses, including SARS-CoV-2, cause AEC apoptosis, mitochondrial fission, and bioenergetic impairment. SARS-CoV-2 also suppresses HPV by targeting mitochondria. This mitochondriopathy is replicated by transduction with SARS-CoV-2 proteins, indicating a mechanistic role for viral-host mitochondrial protein interactions. Mitochondriopathy is a conserved feature of coronaviral pneumonia that may exacerbate hypoxemia and constitutes a therapeutic target. |
format | Online Article Text |
id | pubmed-9558649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95586492022-10-16 SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia Archer, Stephen L. Dasgupta, Asish Chen, Kuang-Hueih Wu, Danchen Baid, Kaushal Mamatis, John E. Gonzalez, Victoria Read, Austin Bentley, Rachel ET. Martin, Ashley Y. Mewburn, Jeffrey D. Dunham-Snary, Kimberly J. Evans, Gerald A. Levy, Gary Jones, Oliver Al-Qazazi, Ruaa Ring, Brooke Alizadeh, Elahe Hindmarch, Charles CT. Rossi, Jenna Lima, Patricia DA. Falzarano, Darryl Banerjee, Arinjay Colpitts, Che C. Redox Biol Research Paper RATIONALE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and bioenergetic impairment, and impairing hypoxic pulmonary vasoconstriction (HPV), respectively. OBJECTIVES: We examined the effects of: A) human betacoronaviruses, SARS-CoV-2 and HCoV-OC43, and individual SARS-CoV-2 proteins on apoptosis, mitochondrial fission, and bioenergetics in AEC; and B) SARS-CoV-2 proteins and mouse hepatitis virus (MHV-1) infection on HPV. METHODS: We used transcriptomic data to identify temporal changes in mitochondrial-relevant gene ontology (GO) pathways post-SARS-CoV-2 infection. We also transduced AECs with SARS-CoV-2 proteins (M, Nsp7 or Nsp9) and determined effects on mitochondrial permeability transition pore (mPTP) activity, relative membrane potential, apoptosis, mitochondrial fission, and oxygen consumption rates (OCR). In human PASMC, we assessed the effects of SARS-CoV-2 proteins on hypoxic increases in cytosolic calcium, an HPV proxy. In MHV-1 pneumonia, we assessed HPV via cardiac catheterization and apoptosis using the TUNEL assay. RESULTS: SARS-CoV-2 regulated mitochondrial apoptosis, mitochondrial membrane permeabilization and electron transport chain (ETC) GO pathways within 2 hours of infection. SARS-CoV-2 downregulated ETC Complex I and ATP synthase genes, and upregulated apoptosis-inducing genes. SARS-CoV-2 and HCoV-OC43 upregulated and activated dynamin-related protein 1 (Drp1) and increased mitochondrial fission. SARS-CoV-2 and transduced SARS-CoV-2 proteins increased apoptosis inducing factor (AIF) expression and activated caspase 7, resulting in apoptosis. Coronaviruses also reduced OCR, decreased ETC Complex I activity and lowered ATP levels in AEC. M protein transduction also increased mPTP opening. In human PASMC, M and Nsp9 proteins inhibited HPV. In MHV-1 pneumonia, infected AEC displayed apoptosis and HPV was suppressed. BAY K8644, a calcium channel agonist, increased HPV and improved SpO(2). CONCLUSIONS: Coronaviruses, including SARS-CoV-2, cause AEC apoptosis, mitochondrial fission, and bioenergetic impairment. SARS-CoV-2 also suppresses HPV by targeting mitochondria. This mitochondriopathy is replicated by transduction with SARS-CoV-2 proteins, indicating a mechanistic role for viral-host mitochondrial protein interactions. Mitochondriopathy is a conserved feature of coronaviral pneumonia that may exacerbate hypoxemia and constitutes a therapeutic target. Elsevier 2022-10-13 /pmc/articles/PMC9558649/ /pubmed/36334378 http://dx.doi.org/10.1016/j.redox.2022.102508 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Archer, Stephen L. Dasgupta, Asish Chen, Kuang-Hueih Wu, Danchen Baid, Kaushal Mamatis, John E. Gonzalez, Victoria Read, Austin Bentley, Rachel ET. Martin, Ashley Y. Mewburn, Jeffrey D. Dunham-Snary, Kimberly J. Evans, Gerald A. Levy, Gary Jones, Oliver Al-Qazazi, Ruaa Ring, Brooke Alizadeh, Elahe Hindmarch, Charles CT. Rossi, Jenna Lima, Patricia DA. Falzarano, Darryl Banerjee, Arinjay Colpitts, Che C. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia |
title | SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia |
title_full | SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia |
title_fullStr | SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia |
title_full_unstemmed | SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia |
title_short | SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia |
title_sort | sars-cov-2 mitochondriopathy in covid-19 pneumonia exacerbates hypoxemia |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558649/ https://www.ncbi.nlm.nih.gov/pubmed/36334378 http://dx.doi.org/10.1016/j.redox.2022.102508 |
work_keys_str_mv | AT archerstephenl sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT dasguptaasish sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT chenkuanghueih sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT wudanchen sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT baidkaushal sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT mamatisjohne sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT gonzalezvictoria sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT readaustin sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT bentleyrachelet sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT martinashleyy sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT mewburnjeffreyd sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT dunhamsnarykimberlyj sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT evansgeralda sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT levygary sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT jonesoliver sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT alqazaziruaa sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT ringbrooke sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT alizadehelahe sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT hindmarchcharlesct sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT rossijenna sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT limapatriciada sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT falzaranodarryl sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT banerjeearinjay sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia AT colpittschec sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia |